Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • VEGF-A and FLT-1 tumour gene e...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

書目詳細資料
Main Authors: Brueckl, WM, Wirtz, R, Dimmler, A, Brunner, T, Klein, P, Hahn, E, Ficker, J, Wiest, G
格式: Journal article
出版: 2009
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽
實物特徵
總結:

相似書籍

  • TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
    由: Papadopoulos Thomas, et al.
    出版: (2007-08-01)
  • Development and Validation of a Simplified Prognostic Score in SCLC
    由: Elodie Negre, MD, et al.
    出版: (2020-03-01)
  • Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
    由: Jin Yujuan, et al.
    出版: (2023-05-01)
  • Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
    由: Jiaping Liu, et al.
    出版: (2024-06-01)
  • Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
    由: Kana Hashimoto, MD, et al.
    出版: (2024-11-01)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題